Basilea Pharmaceutica AG
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Basilea Pharmaceutica AG's balance sheet done over the years? Its assets were worth $173,289,000 last year, which is less than in the previous period. 106% of Basilea Pharmaceutica AG’s total assets is currently financed by debt. Its liabilities reached the amount of $183,292,000, which means an decrease by -24% compared compared to last year.
Debt to Assets
| 2014 | 257378000 | 199.44M | 77.49% |
|---|---|---|---|
| 2015 | 398735000 | 383.87M | 96.27% |
| 2016 | 327758000 | 362.75M | 110.68% |
| 2017 | 351165000 | 392.60M | 111.8% |
| 2018 | 281751000 | 348.43M | 123.67% |
| 2019 | 221467000 | 314.42M | 141.97% |
| 2020 | 229794000 | 331.84M | 144.41% |
| 2021 | 247267000 | 305.87M | 123.7% |
| 2022 | 220848000 | 241.56M | 109.38% |
| 2023 | 173289000 | 183.29M | 105.77% |
BSLN.SW Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 59.9M | 36.56M | 54.95M | 55.60M | 54.52M | 173.03M | 200.72M | 239.03M | 313.06M | 156.12M |
Short term investments | 0 | 50M | 95M | 111.67M | 76.52M | 50M | 60M | 0 | 51.62M | 70M |
Net receivables | 27.89M | 61.70M | 64.44M | 32.39M | 28.29M | 3.75M | 15.02M | 2.49M | 1.54M | 8.19M |
Inventory | 26.41M | 24.24M | 22.78M | 21.19M | 18.56M | 14.41M | 15.32M | 14.93M | 9.57M | 4.90M |
Other current assets | 37.94M | 2.84M | 3.88M | 2.66M | 6.95M | 33.53M | 1.90M | 12.04M | 9.05M | 5.34M |
Total current assets | 152.14M | 175.36M | 241.06M | 223.52M | 184.86M | 274.73M | 292.97M | 268.49M | 384.86M | 244.57M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 20.55M | 21.57M | 2.92M | 5.27M | 5.16M | 6.42M | 7.76M | 8.87M | 10.72M | 12.15M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 548K | 578K | 632K | 672K | 372K | 372K | 326K | 232K | 346K | 224K |
Long term investments | 0 | 23.26M | 2.39M | 0 | 30M | 0 | 50M | 50M | 0 | 0 |
Other non-current assets | 44K | 69K | 256K | 319K | 1.07M | -6.79M | -58.09M | -59.11M | -11.07M | -12.38M |
Total non-current assets | 21.14M | 45.48M | 6.20M | 6.26M | 36.60M | 6.79M | 58.09M | 59.11M | 11.07M | 12.38M |
Total assets | 173.28M | 220.84M | 247.26M | 229.79M | 221.46M | 281.75M | 351.16M | 327.75M | 398.73M | 257.37M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 1.23M | 1.23M | 1.23M | 2.55M | 32.87M | 25.02M | 49.92M | 52M | 50M | 0 |
Short term debt | 17.51M | 39.45M | 124.40M | 1.75M | 1 | -25.02M | 0 | -52M | 0 | 0 |
Total current liabilities | 47.59M | 74.85M | 174.40M | 50.16M | 75.49M | 66.68M | 79.49M | 72.91M | 68.83M | 61.69M |
| Non-current liabilities: | ||||||||||
Long term debt | 111.09M | 131.36M | 94.54M | 239.66M | 197.74M | 196.98M | 196.22M | 195.46M | 194.70M | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 15.14M | 8.33M | 24.98M | 27.95M | 24.72M | -196.98M | 16.48M | -75M | 120.33M | 137.75M |
Total non-current liabilities | 135.7M | 166.71M | 131.46M | 281.67M | 238.93M | 196.98M | 196.22M | 195.46M | 194.70M | 137.75M |
Total liabilities | 183.29M | 241.56M | 305.87M | 331.84M | 314.42M | 348.43M | 392.60M | 362.75M | 383.87M | 199.44M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |